ACTIVE

DOKTERS DEWANDRE-NYSEN

Financial year 2025 · Closed on 31/12/2025

Net result398,2 k €-4,9 %over 1 year
Gross margin655,8 k €+5,1 %over 1 year
Equity2,5 M €+18,8 %over 1 year
Workforce0,0 ETP

Identity

Source · BCE/KBO

DOKTERS DEWANDRE-NYSEN is a Private limited company incorporated in 1997. Its main activity is: Specialist medical practice activities. Its registered office is in Hasselt.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0460.660.720
Incorporation
15/05/1997
Legal form
Private limited company
Registered office
Oude Luikerbaan 126
3500 Hasselt · FlandreSee on map
Contributed capital
6 205,32 €
Latest accounts
31/12/2025
Average workforce
0,0 ETP
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 19 filings

Trend over 19 financial years

20252024202320222021
Income statement
Gross margin655,8 k €624,2 k €590,4 k €621,4 k €544,4 k €
EBITDA649,2 k €617,5 k €583,8 k €614,8 k €538,7 k €
Operating result580,1 k €555,4 k €543,9 k €578,1 k €489,1 k €
Net result398,2 k €418,8 k €434 k €299,7 k €456,4 k €
Balance sheet
Equity2,5 M €2,1 M €1,9 M €1,8 M €1,5 M €
Total assets2,7 M €2,2 M €2,1 M €1,9 M €1,7 M €
Cash397,9 k €46,4 k €233,5 k €197,5 k €304,5 k €
Debts152,7 k €131,8 k €128,7 k €110,5 k €180,5 k €
Other
Workforce0,0 ETP0,0 ETP0,0 ETP0,0 ETP–

Valuation

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 7 ended

Active mandates

Jan Dewandre

Director · since 19 décembre 2019 · until 07 avril 2026

Active
Marleen Nysen

Director

Active

Ended mandates

Jan Dewandre

Director · since 19 décembre 2019

Ended
Marleen Nysen

Director · since 19 décembre 2019

Ended
Jan Dewandre

Manager · since 18 décembre 2013 · until 18 décembre 2019

Ended
Marleen Nysen

Manager · since 18 décembre 2013 · until 18 décembre 2019

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date22/07/202623/07/202523/07/202411/08/202328/07/202229/06/2021
General meeting30/06/202630/06/202528/06/202430/06/202328/06/202201/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202530/06/202622/07/2026DutchPDF
Abridged model31/12/202430/06/202523/07/2025DutchPDF
Abridged model31/12/202328/06/202423/07/2024DutchPDF
Abridged model31/12/202230/06/202311/08/2023DutchPDF
Abridged model31/12/202128/06/202228/07/2022DutchPDF
Abridged model31/12/202001/06/202129/06/2021DutchPDF
Abridged model31/12/201916/06/202014/07/2020DutchPDF
Abridged model31/12/201804/06/201908/07/2019DutchPDF
Abridged model31/12/201705/06/201831/08/2018DutchPDF
Abridged model31/12/201606/06/201731/08/2017DutchPDF
Abridged model31/12/201507/06/201628/06/2016DutchPDF
Abridged model31/12/201423/06/201523/07/2015DutchPDF
Abridged model31/12/201330/06/201405/08/2014DutchPDF
Abridged model31/12/201218/06/201316/07/2013DutchPDF
Abridged model31/12/201105/06/201229/06/2012DutchPDF
Abridged model31/12/201028/06/201127/07/2011DutchPDF
Abridged model31/12/200922/06/201029/06/2010DutchPDF
Abridged model30/06/200823/12/200826/01/2009DutchPDF
Abridged model30/06/200726/12/200718/01/2008DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 7 ended

Active mandates

Jan Dewandre

Director · since 19 décembre 2019 · until 07 avril 2026

Active
Marleen Nysen

Director

Active

Ended mandates

Jan Dewandre

Director · since 19 décembre 2019

Ended
Marleen Nysen

Director · since 19 décembre 2019

Ended
Jan Dewandre

Manager · since 18 décembre 2013 · until 18 décembre 2019

Ended
Marleen Nysen

Manager · since 18 décembre 2013 · until 18 décembre 2019

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates09/03/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates30/01/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates13/01/2014
    BENAMING - DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Other04/06/2009
    ALGEMENE VERGADERING - BOEKJAAR
    PDF
  • Capital / shares07/04/2004
    KAPITAAL - AANDELEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025398,2 k €↓
  2. 2024
    Annual accounts 2024418,8 k €↓
  3. 2023
    Annual accounts 2023434 k €↑
  4. 2022
    Annual accounts 2022299,7 k €↓
  5. 2021
    Annual accounts 2021456,4 k €↑
  6. 2020
    Annual accounts 2020214 k €↓
  7. 2019
    Annual accounts 2019270,7 k €↑
  8. 2018
    Annual accounts 2018231,1 k €↓
  9. 2017
    Annual accounts 2017233,2 k €↑
  10. 2016
    Annual accounts 201696,4 k €↓
  11. 2015
    Annual accounts 2015183,5 k €↓
  12. 2014
    Annual accounts 2014252,6 k €↓
  13. 2013
    Annual accounts 2013312,3 k €↑
  14. 2013
    Name changeDokters Dewandre-Nysen
  15. 2012
    Annual accounts 2012300 k €↑
  16. 2011
    Annual accounts 2011179,1 k €↓
  17. 2010
    Annual accounts 2010473,4 k €↑
  18. 2009
    Annual accounts 2009396,7 k €↑
  19. 2008
    Annual accounts 2008254,7 k €↓
  20. 2007
    Annual accounts 2007257,7 k €
  21. 2007
    Name changeDOKTER DEWANDRE JAN
  22. 15/05/1997
    IncorporationPrivate limited company